| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733694 | Critical Reviews in Oncology/Hematology | 2018 | 9 Pages |
Abstract
Family doctors and clinicians should inform their patients about the increased risk of skin cancer associated with the use of CCB and β-blockers and instruct them to perform periodic skin self-examination. Further studies are warranted to elucidate the observed associations.
Keywords
SCCNMSCCCBARBSRRBCCAngiotensin converting enzyme inhibitorsDiureticsUltravioletβ-blockersMelanomaRelative riskAnti-hypertensive drugsSquamous cell cancerbasal cell cancerNon-melanoma skin cancerconfidence intervalsMeta-analysisReviewCalcium channel blockersAngiotensin receptor blockersACEI یا angiotensin convert enzyme inhibitor
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Sara Gandini, Domenico Palli, Giuseppe Spadola, Benedetta Bendinelli, Emilia Cocorocchio, Ignazio Stanganelli, Lucia Miligi, Giovanna Masala, Saverio Caini,